Daniela Matei

20.6k total citations · 10 hit papers
232 papers, 13.8k citations indexed

About

Daniela Matei is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Daniela Matei has authored 232 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 81 papers in Oncology and 70 papers in Reproductive Medicine. Recurrent topics in Daniela Matei's work include Ovarian cancer diagnosis and treatment (70 papers), Epigenetics and DNA Methylation (31 papers) and RNA modifications and cancer (23 papers). Daniela Matei is often cited by papers focused on Ovarian cancer diagnosis and treatment (70 papers), Epigenetics and DNA Methylation (31 papers) and RNA modifications and cancer (23 papers). Daniela Matei collaborates with scholars based in United States, United Kingdom and Germany. Daniela Matei's co-authors include Kenneth P. Nephew, Ursula A. Matulonis, Jeanne M. Schilder, Ignace Vergote, Jonathan A. Ledermann, Michael Friedländer, Tamar Safra, Werner Meier, Philipp Harter and Ronnie Shapira‐Frommer and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Daniela Matei

220 papers receiving 13.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

2012 1.3k citations Daniela Matei et al. profile →
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

2014 1.1k citations Daniela Matei et al. profile →
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

2008 1.1k citations Shu Zhang, Curt Balch et al. Cancer Research profile →
Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.

2002 502 citations Daniela Matei et al. profile →
Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells

2016 445 citations Salvatore Condello, Daniela Matei et al. profile →
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

2019 377 citations Angeles Alvarez Secord, Gini F. Fleming et al. profile →
Targeting Cancer Stemness in the Clinic: From Hype to Hope

2018 367 citations Daniela Matei et al. profile →
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

2016 309 citations Daniela Matei et al. profile →
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

2019 289 citations Daniela Matei et al. profile →
Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells

2022 177 citations Guangyuan Zhao, Horacio Cárdenas et al. profile →

Peers

Countries citing papers authored by Daniela Matei

Since Specialization

Citations

This map shows the geographic impact of Daniela Matei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Matei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Matei more than expected).

Fields of papers citing papers by Daniela Matei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Matei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Matei. The network helps show where Daniela Matei may publish in the future.

Co-authorship network of co-authors of Daniela Matei

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Matei. A scholar is included among the top collaborators of Daniela Matei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Matei. Daniela Matei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tropical and mid-latitude causal drivers of the eastern Mediterranean Etesians during boreal summer 2024 ·Climate Dynamics ·Giorgia Di Capua, Evangelos Tyrlis, Daniela Matei, Reik V. Donner	2
2	Integrated Multi-Omic Analysis Reveals Immunosuppressive Phenotype Associated with Poor Outcomes in High-Grade Serous Ovarian Cancer 2023 ·Cancers ·(unknown), Masha Kocherginsky, Ramana V. Davuluri, Daniela Matei	5
3	Metabolic dependencies and targets in ovarian cancer 2023 ·Pharmacology & Therapeutics ·Yaqi Zhang, Yinu Wang, Guangyuan Zhao, Sandra Oršulić, Daniela Matei	32
4	N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase 2023 ·Molecular Cancer Therapeutics ·Hao Huang, Guangyuan Zhao, Horacio Cárdenas, (unknown), Yinu Wang, Daniela Matei	12
5	Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium 2022 ·Cancer Research Communications ·Emma L. Barber, Siqi Chen, Mario Javier Pineda, Sharon E. Robertson, Emily K. Hill, Deanna Teoh, Jeanne M. Schilder, (unknown), Masha Kocherginsky, Bin Zhang, Daniela Matei	7
6	DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling 2022 ·Molecular Cancer Research ·Yaqi Zhang, Yinu Wang, (unknown), Hao Huang, Daniela Matei	9
7	The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer 2021 ·Cancer Research ·Monal Patel, Yinu Wang, Elizabeth T. Bartom, (unknown), Kenneth P. Nephew, Daniela Matei, Andrea E. Murmann, Ernst Lengyel, Marcus E. Peter	15
8	Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin 2019 ·Molecular Cancer Therapeutics ·Livia Elena Sima, Bakhtiyor Yakubov, Sheng Zhang, Salvatore Condello, Arabela A. Grigorescu, (unknown), Lan Chen, Gary E. Schiltz, (unknown), Zhong‐Yin Zhang, Daniela Matei	17
9	A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses 2018 ·Clinical Cancer Research ·Daniela Matei, Sharad Ghamande, Lynda D. Roman, Angeles Alvarez Secord, John Nemunaitis, Merry Jennifer Markham, Kenneth P. Nephew, Simone Jueliger, Aram Oganesian, Sue Naim, (unknown), Harold Keer, Mohammad Azab, Gini F. Fleming	46
10	An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations 2018 ·Clinical Cancer Research ·(unknown), Fang Fang, Ali Özeş, Jessica Tang, (unknown), Harold Keer, John F. Lyons, Stephen B. Baylin, Daniela Matei, Harikrishna Nakshatri, Feyruz V. Rassool, Kathy D. Miller, Kenneth P. Nephew	95
11	Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche 2018 ·Cancer Research ·Salvatore Condello, Livia Elena Sima, Cristina Ivan, Horacio Cárdenas, Gary E. Schiltz, Rama K. Mishra, Daniela Matei	50
12	Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs 2017 ·Cancer Research ·Fang Fang, Horacio Cárdenas, Hao Huang, Guanglong Jiang, Susan M. Perkins, Chi Zhang, Harold Keer, Yunlong Liu, Kenneth P. Nephew, Daniela Matei	78
13	Tissue Transglutaminase Mediated Tumor–Stroma Interaction Promotes Pancreatic Cancer Progression 2015 ·Clinical Cancer Research ·Jiyoon Lee, Salvatore Condello, Bakhtiyor Yakubov, Robert E. Emerson, Andrea Caperell–Grant, Kiyotaka Hitomi, Jingwu Xie, Daniela Matei	72
14	The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer 2014 ·Clinical Cancer Research ·Fang Fang, Joanne M. Munck, Jessica Tang, Pietro Taverna, Yinu Wang, David F. Miller, Jay Pilrose, Gavin Choy, Mohammad Azab, Katherine S. Pawelczak, Pamela S. VanderVere-Carozza, Michael Wagner, John F. Lyons, Daniela Matei, John J. Turchi, Kenneth P. Nephew	81
15	Epigenetic Targeting of Ovarian Cancer Stem Cells 2014 ·Cancer Research ·Yinu Wang, Horacio Cárdenas, Fang Fang, Salvatore Condello, Pietro Taverna, Matthew W. Segar, Yunlong Liu, Kenneth P. Nephew, Daniela Matei	120
16	Targeting the Insulin Growth Factor and the Vascular Endothelial Growth Factor Pathways in Ovarian Cancer 2012 ·Molecular Cancer Therapeutics ·Minghai Shao, (unknown), (unknown), (unknown), Robert E. Emerson, Bhadrani Chelladurai, Susan M. Perkins, Mircea Ivan, Daniela Matei	27
17	Epigenetic Resensitization to Platinum in Ovarian Cancer 2012 ·Cancer Research ·Daniela Matei, Fang Fang, Changyu Shen, Jeanne M. Schilder, (unknown), Yan Zeng, William Berry, Tim H.‐M. Huang, Kenneth P. Nephew	302
18	Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase 2009 ·Cancer Research ·Minghai Shao, Liyun Cao, Changyu Shen, Minati Satpathy, Bhadrani Chelladurai, Robert M. Bigsby, Harikrishna Nakshatri, Daniela Matei	118
19	Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors breakdown → 2008 ·Cancer Research ·Shu Zhang, Curt Balch, Michael W.Y. Chan, Hung‐Cheng Lai, Daniela Matei, Jeanne M. Schilder, Pearlly S. Yan, Tim H-M. Huang, Kenneth P. Nephew	1055
20	Enhanced Peritoneal Ovarian Tumor Dissemination by Tissue Transglutaminase 2007 ·Cancer Research ·Minati Satpathy, Liyun Cao, Roxana Pincheira, Robert E. Emerson, Robert M. Bigsby, Harikrishna Nakshatri, Daniela Matei	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact